ZA98679B - Use of quinoxalines in a triple combination with protease inhibitors and reverse transcriptase inhibitors as medicaments for the treatment of aids and/or hiv infections - Google Patents

Use of quinoxalines in a triple combination with protease inhibitors and reverse transcriptase inhibitors as medicaments for the treatment of aids and/or hiv infections

Info

Publication number
ZA98679B
ZA98679B ZA98679A ZA98679A ZA98679B ZA 98679 B ZA98679 B ZA 98679B ZA 98679 A ZA98679 A ZA 98679A ZA 98679 A ZA98679 A ZA 98679A ZA 98679 B ZA98679 B ZA 98679B
Authority
ZA
South Africa
Prior art keywords
quinoxalines
medicaments
aids
treatment
reverse transcriptase
Prior art date
Application number
ZA98679A
Other languages
English (en)
Inventor
Arnold Paessens
Martin Blunck
Gunter Riess
Jorg-Peter Kleim
Manfred Rosner
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA98679B publication Critical patent/ZA98679B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA98679A 1997-01-29 1998-01-28 Use of quinoxalines in a triple combination with protease inhibitors and reverse transcriptase inhibitors as medicaments for the treatment of aids and/or hiv infections ZA98679B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19703131A DE19703131A1 (de) 1997-01-29 1997-01-29 Verwendung von Chinoxalin in Dreier-Kombination mit Protease-Inhibitoren und Reverse Transkriptaseinhibitoren als Arzneimittel zur Behandlung von AIDS und/oder HIV-Infektionen

Publications (1)

Publication Number Publication Date
ZA98679B true ZA98679B (en) 1998-08-05

Family

ID=7818634

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA98679A ZA98679B (en) 1997-01-29 1998-01-28 Use of quinoxalines in a triple combination with protease inhibitors and reverse transcriptase inhibitors as medicaments for the treatment of aids and/or hiv infections

Country Status (16)

Country Link
EP (1) EP0977570A1 (es)
JP (1) JP2001511124A (es)
KR (1) KR20000070543A (es)
CN (1) CN1251525A (es)
AR (1) AR011094A1 (es)
AU (1) AU6094098A (es)
BR (1) BR9807523A (es)
CA (1) CA2278773A1 (es)
DE (1) DE19703131A1 (es)
ID (1) ID22414A (es)
IL (1) IL130877A0 (es)
NO (1) NO993670L (es)
PL (1) PL334770A1 (es)
SK (1) SK99899A3 (es)
WO (1) WO1998032442A1 (es)
ZA (1) ZA98679B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999060988A2 (en) * 1998-05-29 1999-12-02 University Of Florida Combination therapy for treatment of fiv infection
US6875773B1 (en) 1998-05-29 2005-04-05 Ben M. Dunn Combination therapy for treatment of FIV infection
AU6329599A (en) * 1998-09-28 2000-04-17 Glaxo Group Limited Antiviral combinations comprising (s)-2-ethyl -7-fluoro -3-oxo-3, 4-dihydro -2h-quinoxaline -1-carboxylic acid isopropyl ester
GB9821000D0 (en) * 1998-09-28 1998-11-18 Glaxo Group Ltd Antiviral combinations
GB9911887D0 (en) * 1999-05-21 1999-07-21 Glaxo Group Ltd Methods and medicaments for post exposure prophylaxis of an hiv infection
SE9902987D0 (sv) 1999-08-24 1999-08-24 Astra Pharma Prod Novel compounds
CO5300399A1 (es) 2000-02-25 2003-07-31 Astrazeneca Ab Heterocicliocs que contienen nitrogeno, proceso para su preparacion y composiciones farmaceuticas que los contienen
US7005439B2 (en) 2000-06-20 2006-02-28 Astrazeneca Ab Compounds
AR028948A1 (es) 2000-06-20 2003-05-28 Astrazeneca Ab Compuestos novedosos
GB0104050D0 (en) 2001-02-19 2001-04-04 Astrazeneca Ab Chemical compounds
AR035230A1 (es) 2001-03-19 2004-05-05 Astrazeneca Ab Compuestos de bencimidazol, proceso para su preparacion, composicion farmaceutica, proceso para la preparacion de dicha composicion farmaceutica, y usos de estos compuestos para la elaboracion de medicamentos
GB0107228D0 (en) 2001-03-22 2001-05-16 Astrazeneca Ab Chemical compounds
SE0101038D0 (sv) 2001-03-23 2001-03-23 Astrazeneca Ab Novel compounds
SE0103818D0 (sv) 2001-11-15 2001-11-15 Astrazeneca Ab Chemical compounds
SE0301369D0 (sv) 2003-05-09 2003-05-09 Astrazeneca Ab Chemical compounds
US7351709B2 (en) 2004-06-09 2008-04-01 Wyeth Estrogen receptor ligands
TW200738634A (en) 2005-08-02 2007-10-16 Astrazeneca Ab New salt
CA2633400A1 (en) * 2005-12-15 2007-06-21 Bayer Healthcare Ag Diaryl urea for treating virus infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2164639T3 (es) * 1991-04-15 2002-03-01 Aventis Pharma Gmbh Quinoxalinas, procedimiento para su preparacion y su empleo.
DE4342024A1 (de) * 1993-12-09 1995-06-14 Hoechst Ag Kombinationspräparate, enthaltend ein Chinoxalin und ein Nukleosid
DE19506742A1 (de) * 1995-02-27 1996-08-29 Bayer Ag Verwendung von Chinoxalinen in Kombination mit Protease-Inhibitoren als Arzneimittel zur Behandlung von AIDS und/oder HIV-Infektionen

Also Published As

Publication number Publication date
JP2001511124A (ja) 2001-08-07
DE19703131A1 (de) 1998-07-30
AU6094098A (en) 1998-08-18
NO993670D0 (no) 1999-07-28
NO993670L (no) 1999-09-10
IL130877A0 (en) 2001-01-28
PL334770A1 (en) 2000-03-13
CA2278773A1 (en) 1998-07-30
KR20000070543A (ko) 2000-11-25
SK99899A3 (en) 2000-03-13
BR9807523A (pt) 2000-03-21
EP0977570A1 (de) 2000-02-09
AR011094A1 (es) 2000-08-02
CN1251525A (zh) 2000-04-26
ID22414A (id) 1999-10-14
WO1998032442A1 (de) 1998-07-30

Similar Documents

Publication Publication Date Title
ZA98679B (en) Use of quinoxalines in a triple combination with protease inhibitors and reverse transcriptase inhibitors as medicaments for the treatment of aids and/or hiv infections
AU2001293553A1 (en) Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment
IL144294A0 (en) P53 inhibitors and therapeutic use of the same
HUP0203367A3 (en) Benzylidine-thiazolidinediones and analogues and their use in the treatment of diabetes
FI955315A0 (fi) HIV:n proteaasin inhibiittoreita, jotka ovat käyttökelpoisia AIDS'n hoitoon
AU2001256184A1 (en) 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viraldiseases
IL139002A0 (en) Compositions for the treatment of hiv and other viral infections
AU5127098A (en) Use of a combination of penciclovir and alpha-interferon in the manufacture of a medicament for the treatment of hepatitis
HUP0203249A3 (en) Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders
ZA961516B (en) Use of quinoxalines in combination with protease inhibitors as medicament for treatis aids and/or hiv infections
PT946175E (pt) Utilizacao de uma combinacao de inibidores de h+, k+ -atpase e de glucocorticiodes no tratamento de polipos nasais
ZA975288B (en) The use of TCET in the prophylaxis and treatment of allergies.
FI935780A (fi) HIV-proteaasin inhibiittoreita, jotka ovat hyödyllisiä AIDSin hoitoa varten
EP1014992A4 (en) USE OF DELTA 5-ANDROSTENES IN THE TREATMENT OF HIV-RELATED LOSS SYNDROME
EP0681787A3 (en) Use of an enzyme for the manufacture of an agent suitable for the treatment and / or prophylaxis of coccidiosis.
NZ525774A (en) Use of SARP-1 for the treatment and/or prevention of scleroderma
AU1873101A (en) Synergistic treatment of dna viral infections
AU1389897A (en) Use of chemokines for the treatment and prevention of hiv infection
AU9341398A (en) Protease precursors that can be autocatalytically activated and their use
AU2002237251A1 (en) A pharmaceutical composition containing benzopyrano-oxopyrimidotetrahydrothiazine and its use in the treatment of hiv
AU7684000A (en) Interferon complex and medicinal use thereof
AU2001260291A1 (en) Combination of cerivastatin with ace inhibitors and the use thereof in medicaments
AU2002351176A1 (en) Peptides and use thereof in therapeutic agents against hiv infection
GB9613488D0 (en) HIV protease inhibitors useful in the treatment of aids
IL143795A0 (en) Use of 3-isoxazolidinones and hydroxylamic acids for the treatment of infections